Literature DB >> 22532554

Mutation in an mtDNA protein-coding gene: prenatal diagnosis aided by fetal muscle biopsy.

Sara Shanske1, Ali Naini, Ramen H Chmait, Hasan O Akman, Mahesh Mansukhani, Jiesheng Lu, Michio Hirano, Salvatore DiMauro.   

Abstract

Prenatal diagnosis of disorders due to mitochondrial DNA (mtDNA) tRNA gene mutations is problematic. Experience in families harboring the protein-coding ATPase 6 m.8993T>G mutation suggests that the mutant load is homogeneous in different tissues, thus allowing prenatal diagnosis. We have encountered a novel protein-coding gene mutation, m.10198C>T in MT-ND3. A baby girl homoplasmic for this mutation died at 3 months after severe psychomotor regression and respiratory arrest. The mother had no detectable mutation in accessible tissues. The product of a second pregnancy showed only wild-type mt genomes in amniocytes, chorionic villi, and biopsied fetal muscle. This second girl is now 18 months old and healthy. Our observations support the concept that the pathogenic mutation in this patient appeared de novo and that fetal muscle biopsy is a useful aide in prenatal diagnosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22532554      PMCID: PMC3959766          DOI: 10.1177/0883073812441067

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  23 in total

1.  Optical imaging techniques (histochemical, immunohistochemical, and in situ hybridization staining methods) to visualize mitochondria.

Authors:  K Tanji; E Bonilla
Journal:  Methods Cell Biol       Date:  2001       Impact factor: 1.441

2.  Prenatal diagnosis of mitochondrial DNA8993 T----G disease.

Authors:  A E Harding; I J Holt; M G Sweeney; M Brockington; M B Davis
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

3.  Two cases of prenatal analysis for the pathogenic T to G substitution at nucleotide 8993 in mitochondrial DNA.

Authors:  S L White; S Shanske; I Biros; L Warwick; H M Dahl; D R Thorburn; S Di Mauro
Journal:  Prenat Diagn       Date:  1999-12       Impact factor: 3.050

4.  Cytochrome c oxidase deficiency in Leigh syndrome.

Authors:  S DiMauro; S Servidei; M Zeviani; M DiRocco; D C DeVivo; S DiDonato; G Uziel; K Berry; G Hoganson; S D Johnsen
Journal:  Ann Neurol       Date:  1987-10       Impact factor: 10.422

5.  Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 gene.

Authors:  R W Taylor; R Singh-Kler; C M Hayes; P E Smith; D M Turnbull
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

6.  Recurrent de novo mitochondrial DNA mutations in respiratory chain deficiency.

Authors:  S Lebon; M Chol; P Benit; C Mugnier; D Chretien; I Giurgea; I Kern; E Girardin; L Hertz-Pannier; P de Lonlay; A Rötig; P Rustin; A Munnich
Journal:  J Med Genet       Date:  2003-12       Impact factor: 6.318

7.  Prenatal exclusion of Leigh syndrome due to T8993C mutation in the mitochondrial DNA.

Authors:  Esther Leshinsky-Silver; Michal Perach; Erena Basilevsky; Eli Hershkovitz; Miri Yanoov-Sharav; Tally Lerman-Sagie; Dorit Lev
Journal:  Prenat Diagn       Date:  2003-01       Impact factor: 3.050

8.  Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease.

Authors:  Lyndsey Craven; Helen A Tuppen; Gareth D Greggains; Stephen J Harbottle; Julie L Murphy; Lynsey M Cree; Alison P Murdoch; Patrick F Chinnery; Robert W Taylor; Robert N Lightowlers; Mary Herbert; Douglass M Turnbull
Journal:  Nature       Date:  2010-04-14       Impact factor: 49.962

9.  De novo mutations in the mitochondrial ND3 gene as a cause of infantile mitochondrial encephalopathy and complex I deficiency.

Authors:  Robert McFarland; Denise M Kirby; Kerry J Fowler; Akira Ohtake; Michael T Ryan; David J Amor; Janice M Fletcher; Joanne W Dixon; Felicity A Collins; Douglass M Turnbull; Robert W Taylor; David R Thorburn
Journal:  Ann Neurol       Date:  2004-01       Impact factor: 10.422

10.  A new mitochondrial DNA mutation in ND3 gene causing severe Leigh syndrome with early lethality.

Authors:  Marco Crimi; Alexandros Papadimitriou; Sara Galbiati; Phani Palamidou; Francesco Fortunato; Andreina Bordoni; Urania Papandreou; Dimitra Papadimitriou; George M Hadjigeorgiou; Eurydiki Drogari; Nereo Bresolin; Giacomo Pietro Comi
Journal:  Pediatr Res       Date:  2004-02-05       Impact factor: 3.756

View more
  2 in total

1.  Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy.

Authors:  Kristin Engelstad; Miriam Sklerov; Joshua Kriger; Alexandra Sanford; Johnston Grier; Daniel Ash; Dieter Egli; Salvatore DiMauro; John L P Thompson; Mark V Sauer; Michio Hirano
Journal:  Hum Reprod       Date:  2016-03-02       Impact factor: 6.918

2.  De novo mtDNA point mutations are common and have a low recurrence risk.

Authors:  Suzanne C E H Sallevelt; Christine E M de Die-Smulders; Alexandra T M Hendrickx; Debby M E I Hellebrekers; Irenaeus F M de Coo; Charlotte L Alston; Charlotte Knowles; Robert W Taylor; Robert McFarland; Hubert J M Smeets
Journal:  J Med Genet       Date:  2016-07-22       Impact factor: 6.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.